Visfatin, Leptin, and TNF-α: Interrelated Adipokines in Insulin-Resistant Clinical and Subclinical Hypothyroidism

REFERENCES

• Rochon C, Tauveron I, Dejax C, . Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin Sci (Lond). 2003;104(1):7–15.
   Google Scholar
• Dimitriadis G, Mitrou P, Lambadiari V, . Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab. 2006;91(12):4930–4937.
   Google Scholar
• Dimitriadis G, Parry-Billings M, Bevan S, . The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Eur J Clin Invest. 1997;27(6): 475–483.
   Google Scholar
• Cettour-Rose P, Theander-Carrillo C, Asensio C, . Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion. Diabetologia 2005;48:624–633.
   Google Scholar
• Kokkinos A, Mourouzis I, Kyriaki D, . Possible implications of leptin, adiponectin and ghrelin in the regulation of energy homeostasis by thyroid hormone. Endocrine. 2007;32(1):30–32.
   Google Scholar
• Brenta G, Berg G, Arias P, Zago V, . Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T4 treatment. Thyroid 2007;17:453–460.
   PubMed Web of Science ®Google Scholar
• Al Sayed A, Al Ali N, Bo Abbas Y, . Subclinical hypothyroidism is associated with early insulin resistance in Kuwaiti women. Endocrine J 2006;53:653–657.
   PubMed Web of Science ®Google Scholar
• Kowalska I, Borawski J, Nikołajuk A, . Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy. Endocrine. 2011;40(1):95–101.
   Google Scholar
• Dessein PH, Joffe BI, Stanwix AE. Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid 2004;14:443–446.
   PubMed Web of Science ®Google Scholar
• Tuzcu A, Bahceci M, Gokalp D, . Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. J Endocrinol 2005;52:89–94.
   Google Scholar
• Asvold BO, Vatten LJ, Nilsen TI, . The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study Eur J Endocrinol. 2007;156(2):181–186.
   Google Scholar
• Roos A, Bakker SJ, Links TP, . Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab. 2007;92(2):491–496.
   PubMed Web of Science ®Google Scholar
• Asvold BO, Bjøro T, Nilsen TI, . Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. J Clin Endocrinol Metab. 2007;92(3):841–845.
   Google Scholar
• Lambadiari V, Mitrou P, Maratou E, . Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes. Endocrine. 2011;39(1):28–32.
   Google Scholar
• Chen CC, Li TC, Li CI, . The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women. Metabolism. 2007;56(9):1216–1220.
   Google Scholar
• Filippatos TD, Derdemezis CS, Gazi IF, . Increased plasma visfatin levels in subjects with the metabolic syndrome. Eur J Clin Invest. 2008;38(1):71–72.
   Google Scholar
• Marcinkowska M, Lewandowski KC, Lewiński A, . Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans. Endokrynol Pol. 2007;58(3):188–194.
   Google Scholar
• Gulcelik NE, Usman A, Gurlek A. Role of adipocytokines in predicting the development of diabetes and its late complications. Endocrine. 2009;36(3):397–403.
   Google Scholar
• Fukuhara A, Matsuda M, Nishizawa M, . Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307(5708):426–430.
   PubMed Web of Science ®Google Scholar
• Chen MP. Chang DM . Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295–299.
   PubMed Web of Science ®Google Scholar
• Sethi JK, Vidal-Puig A. Visfatin the missing link between intraabdominal obesity and diabetes?. Trends Mol Med 2005;11:344–347.
   PubMed Web of Science ®Google Scholar
• Ozkaya M, Sahin M, Cakal E, . Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. J Endocrinol Invest. 2009;32(5):435–439.
   PubMed Web of Science ®Google Scholar
• Caixàs A, Tirado R, Vendrell J, . Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters. Clin Endocrinol (Oxf). 2009;71(5):733–738.
   Google Scholar
• Hammarstedt A, Pihlajamäki J, Rotter Sopasakis V, . Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab. 2006;91(3):1181–1184.
   Google Scholar
• Krzyzanowska K, Mittermayer F, Krugluger W, . Increase in visfatin after weight loss induced by gastroplastic surgery. Obesity (Silver Spring). 2006;14(11):1886–1889.
   Google Scholar
• Lewandowski KC, Stojanovic N, Press M, . Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia. 2007;50(5):1033–1037.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffei M, . Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–432.
   PubMed Web of Science ®Google Scholar
• Rohner-Jeanrenaud F, Cusin I, Sainsbury A, . The loop system between neuropeptide Y and leptin in normal and obese rodents. Horm Metab Res. 1996;28(12):642–648.
   Google Scholar
• Fridewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Bonora E, Targher G, Alberiche M, . Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57–63.
   PubMed Web of Science ®Google Scholar
• Acosta AM, Escalona M, Maiz A, . Determination of the insulin resistance index by the Homeostasis Model Assessment in a population of Metropolitan Region in Chile. Rev Med Chil 2002;130:1227–1231.
   PubMed Web of Science ®Google Scholar
• McAuley KA, Williams SM, Mann JI, . Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24(3):460–464.
   PubMed Web of Science ®Google Scholar
• Kim SR, Tull ES, Talbott EO, . A hypothesis of synergism: the interrelationship of T3 and insulin to disturbances in metabolic homeostasis. Med Hypotheses. 2002;59(6):660–666.
   PubMed Web of Science ®Google Scholar
• Kosova F, Sepici-Dincel A, Engin A, . The thyroid hormone mediated effects of insulin on serum leptin levels of diabetic rats. Endocrine. 2008;33(3):317–322.
   Google Scholar
• McCulloch AJ, Johnston DG, Baylis PH, . Evidence that thyroid hormones regulate gluconeogenesis from glycerol in man. Clin Endocrinol. 1983;19(1):67–76.
   Google Scholar
• Peppa M, Koliaki C, Nikolopoulos P, . Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol 2010; (2010):Article ID 52785013.
   Google Scholar
• Maratou E, Hadjidakis DJ, Kollias A, . Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol. 2009;160(5):785–790.
   PubMed Web of Science ®Google Scholar
• Rabe K, Lehrke M, Parhofer KG, . Adipokines and insulin resistance. Mol Med. 2008;14(11–12):741–751.
   PubMed Web of Science ®Google Scholar
• Körner A, Garten A, Blüher M, . Molecular characteristics of serum visfatin and differential detection by immunoassays. J Clin Endocrinol Metab 2007;92:4783–4791.
   PubMed Web of Science ®Google Scholar
• Yang WS, Lee WJ, Funahashi T, . Plasma adiponectin levels in overweight and obese Asians. Obes Res 2002;10:1104–1110.
   PubMedGoogle Scholar
• Jian WX, Luo TH, Gu YY, . The visfatin gene is associated with glucose and lipid metabolism in a Chinese population. Diabet Med 2006;23:967–973.
   PubMed Web of Science ®Google Scholar
• Sandeep S, Velmurugan K, Deepa R, . Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians. Metabolism 2007;56:565–570.
   PubMed Web of Science ®Google Scholar
• Berndt J, Klöting N, Kralisch S, . Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005;54:2911–2916.
   PubMed Web of Science ®Google Scholar
• Dogru T, Sonmez A, Tasci I, . Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 2007;76:24–29.
   PubMed Web of Science ®Google Scholar
• Pagano C, Pilon C, Olivieri M, . Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 2006;91:3165–3170.
   PubMed Web of Science ®Google Scholar
• Chu CH, Lee JK, Wang MC, . Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism. Metabolism. 2008;57(10):1380–1383.
   Google Scholar
• Sun Q, Li L, Li R, . Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats. Ann Med. 2009;41(4):311–320.
   Web of Science ®Google Scholar
• El-Mesallamy HO, Kassem DH, El-Demerdash E, . Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism. 2011;60(1):63–70.
   PubMedGoogle Scholar
• Dahl TB, Yndestad A, Skjelland M, . Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation. 2007;115(8):972–980.
   PubMed Web of Science ®Google Scholar
• Liu SW, Qiao SB, Yuan JS, . Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans. Clin Endocrinol (Oxf). 2009;71(2):202–207.
   Web of Science ®Google Scholar
• Jellema A, Plat J, Mensink RP. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest. 2004;34(11):766–773.
   Google Scholar
• Kieffer TJ, Habener JF. The adipoinsular axis: effects of leptin on pancreatic beta-cells. Am J Physiol Endocrinol Metab. 2000;278(1):E1–E14.
   PubMed Web of Science ®Google Scholar
• Leonhardt U, Ritzel U, Schäfer G, . Serum leptin levels in hypo- and hyperthyroidism. J Endocrinol. 1998;157(1):75–79.
   Google Scholar
• Cabanelas A, Lisboa PC, Moura EG, . Leptin acute modulation of the 5’-deiodinase activities in hypothalamus, pituitary and brown adipose tissue of fed rats. Horm Metab Res. 2006;38(8):481–485.
   Google Scholar
• Lechan RM, FC. The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res 2006;153:209–235.
   PubMedGoogle Scholar
• Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 2001;15(14):2565–2571.
   Google Scholar
• Simons PJ, van den Pangaart PS, van Roomen CP, . Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-alpha- and interleukin-1beta-treated human preadipocytes are potent leptin producers. Cytokine. 2005;32(2):94–103.
   Google Scholar
• Hector J, Schwarzloh B, Goehring J, . TNF-alpha alters visfatin and adiponectin levels in human fat. Horm Metab Res. 2007;39(4):250–255.
   PubMed Web of Science ®Google Scholar
• Lago F, Dieguez C, Gómez-Reino J, . Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol. 2007;3(12):716–724.
   PubMedGoogle Scholar
• Moschen AR, Kaser A, Enrich B, . Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol. 2007;178(3):1748–1758.
   PubMed Web of Science ®Google Scholar